
Robinhood Telehealth Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: budget compounded semaglutide or tirzepatide with flat dose pricing and a microdose option
Robinhood Telehealth scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Robinhood Telehealth is a Texas telehealth platform that connects you with independent prescribers for compounded semaglutide and tirzepatide, plus a GLP-1 microdose, an oral GLP-1 and a long peptide menu. Its catalog lists semaglutide from $159/mo and tirzepatide from $229/mo, billed every 30 days, with the consult and shipping included. The pharmacies and medical group are not named.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Robinhood Telehealth
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
Editorial score · methodology
Robinhood Telehealth at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $159/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Robinhood Telehealth
Each dimension is scored algorithmically from Robinhood Telehealth’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $159/mo, Robinhood Telehealth runs about 6% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.9/10Robinhood Telehealth offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.8/10Robinhood Telehealth's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.6/10Robinhood Telehealth provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Robinhood Telehealth review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $159–$229/mo across 2 dose/plan tiers — checked October 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Robinhood Telehealth
We walked Robinhood Telehealth’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click "Check eligibility" and pick what you want support with (for example, long-term health)
- 2Answer short lifestyle questions on activity, sleep, stress and sex, with a pregnancy question for women
- 3Enter height, current weight and goal weight; a BMI analysis screen shows a projected timeline
- 4Answer about 12 medical screens: body shape, conditions such as thyroid cancer or pancreatitis, surgeries, GLP-1 history, medications, allergies and heart rate
- 5A "Your Medical Review" screen asks for your first and last name, followed by email, phone, date of birth and shipping address (walk stopped here)
- The peptide catalog page lists GLP-1 prices before any quiz: semaglutide from $159/mo, tirzepatide from $229/mo, microdose from $149/mo and oral GLP-1 from $199/mo
- The main semaglutide and tirzepatide pages show no price, only "Available by consultation"
- In the quiz, the treatment picker and its prices come only after you give your name, email, phone, birth date and address
- The homepage advertises 25% off your first order, applied after a physician approves you
- The terms say an auto-refill subscription is charged at once and every 30 days until you cancel, with a reminder 5 to 7 days before each charge
- The site says nothing is charged if you are not approved; we did not take the medication
Robinhood Telehealth customer support
- Phone
- (469) 808-0133
- Hours
- Monday–Friday, 9:00 AM–5:00 PM
GLP-1 medications Robinhood Telehealth offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Listed as "from $159/mo"; the treatment picker shows a struck-through $259 beside it, and new patients get 25% off the first order.
Listed as "from $229/mo"; the treatment picker shows a struck-through $329 beside it, and new patients get 25% off the first order.
Ready to get started?
Plans and promotions change often — check Robinhood Telehealth's current pricing and active discounts before you decide.
What we like
- Semaglutide from $159/mo and tirzepatide from $229/mo, listed on the public treatment catalog before you start the quiz
- Says one flat rate covers every dose, with no consultation charge and no surcharge when your dose changes
- Free 2–3 day shipping, and nothing is charged if a provider does not approve treatment
- Offers a low-dose GLP-1 microdose and a daily oral GLP-1 alongside the weekly injections
- Publishes a phone line, an email address, weekday support hours and a Texas business address
- The eligibility quiz screens for medullary thyroid cancer, MEN 2, pancreatitis and pregnancy
Watch-outs
- Does not name its prescribing medical group or its compounding pharmacies anywhere on the site
- The drug behind the GLP-1 microdose and the oral GLP-1 is never named
- The FAQ asks for 30 days' notice to cancel, while the terms allow canceling up to 48 hours before the next charge
- The plan price is shown in the quiz only after your name, email, phone, date of birth and address
- Prices are shown beside struck-through higher figures, and the site does not say whether renewals stay at the lower price
- No refunds once medication is dispensed, and returned medication carries a $35 disposal fee
- Shows five-star "Google Review" quotes, but no Google, Trustpilot or BBB profile could be found for the brand
- A young brand: its terms are dated June 2026 and the site's domain was registered in March 2026
Is Robinhood Telehealth worth it?
Robinhood Telehealth's whole pitch comes down to this: budget compounded semaglutide or tirzepatide with flat dose pricing and a microdose option. It runs $159/month, the same price at every dose, — squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. Its standout is a needle-free oral option, which very few providers offer.
On top of the core program, it offers a microdosing option and charges the same price at every dose.
How much Robinhood Telehealth actually costs
Compounded semaglutide runs $159/month and compounded tirzepatide runs $229/month.
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
For a direct comparison, SkinnyRx runs semaglutide and tirzepatide from $149.25/month — worth pricing against Robinhood Telehealth before you commit.
Medications: what Robinhood Telehealth prescribes
Robinhood Telehealth prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Robinhood Telehealth's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Robinhood Telehealth is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Robinhood Telehealth is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Midi Health is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Robinhood Telehealth scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Robinhood Telehealth?
Starting at $159/month. See current pricing and start your free consultation.
Robinhood Telehealth might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Robinhood Telehealth review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Robinhood Telehealth's current pricing
Plans start at $159/month. Start your free consultation to check eligibility and today's price.